Yatin Suneja
Stock Analyst at Guggenheim
(4.69)
# 173
Out of 5,146 analysts
158
Total ratings
59.15%
Success rate
27.38%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXSM Axsome Therapeutics | Maintains: Buy | $205 → $220 | $165.17 | +33.20% | 10 | Feb 24, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $760 → $800 | $348.60 | +129.49% | 5 | Feb 10, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $865 → $975 | $787.76 | +23.77% | 9 | Feb 9, 2026 | |
| BIIB Biogen | Maintains: Buy | $185 → $246 | $190.69 | +29.01% | 4 | Feb 9, 2026 | |
| ROIV Roivant Sciences | Maintains: Buy | $28 → $30 | $28.49 | +5.30% | 4 | Feb 9, 2026 | |
| IMVT Immunovant | Maintains: Buy | $41 → $44 | $27.16 | +62.00% | 9 | Feb 9, 2026 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $50 | $16.15 | +209.69% | 1 | Feb 2, 2026 | |
| ALMS Alumis | Maintains: Buy | $18 → $32 | $29.68 | +7.82% | 3 | Jan 7, 2026 | |
| SABS SAB Biotherapeutics | Initiates: Buy | $15 | $3.81 | +293.70% | 1 | Dec 19, 2025 | |
| DBVT DBV Technologies | Maintains: Buy | $35 → $51 | $21.82 | +133.73% | 2 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $22 | $0.95 | +2,214.57% | 6 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $100 | $56.21 | +77.90% | 14 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $14 | $3.43 | +308.76% | 3 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $57.95 | +20.79% | 4 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $35.07 | +71.09% | 1 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $150 | $124.13 | +20.84% | 3 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $112 → $128 | $7.30 | +1,653.42% | 3 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $20 | $18.19 | +9.95% | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $1,070 | $826.18 | +29.51% | 13 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $100 | $52.98 | +88.75% | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $28.43 | +163.81% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $3.74 | +301.61% | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $175 | $131.12 | +33.47% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $5.90 | +340.68% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $29 | $15.38 | +88.56% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $12 | $12.40 | -3.23% | 4 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $7.06 | +112.46% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $26.77 | +68.10% | 3 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $26.47 | +70.02% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $24.76 | -19.22% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.42 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $43.86 | +48.20% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $30.19 | +198.16% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.63 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $44.43 | +10.29% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $17.50 | +214.29% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.46 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $18.53 | +29.52% | 1 | May 31, 2022 |
Axsome Therapeutics
Feb 24, 2026
Maintains: Buy
Price Target: $205 → $220
Current: $165.17
Upside: +33.20%
Praxis Precision Medicines
Feb 10, 2026
Maintains: Buy
Price Target: $760 → $800
Current: $348.60
Upside: +129.49%
Regeneron Pharmaceuticals
Feb 9, 2026
Maintains: Buy
Price Target: $865 → $975
Current: $787.76
Upside: +23.77%
Biogen
Feb 9, 2026
Maintains: Buy
Price Target: $185 → $246
Current: $190.69
Upside: +29.01%
Roivant Sciences
Feb 9, 2026
Maintains: Buy
Price Target: $28 → $30
Current: $28.49
Upside: +5.30%
Immunovant
Feb 9, 2026
Maintains: Buy
Price Target: $41 → $44
Current: $27.16
Upside: +62.00%
Avalo Therapeutics
Feb 2, 2026
Initiates: Buy
Price Target: $50
Current: $16.15
Upside: +209.69%
Alumis
Jan 7, 2026
Maintains: Buy
Price Target: $18 → $32
Current: $29.68
Upside: +7.82%
SAB Biotherapeutics
Dec 19, 2025
Initiates: Buy
Price Target: $15
Current: $3.81
Upside: +293.70%
DBV Technologies
Dec 17, 2025
Maintains: Buy
Price Target: $35 → $51
Current: $21.82
Upside: +133.73%
Nov 10, 2025
Maintains: Buy
Price Target: $10 → $22
Current: $0.95
Upside: +2,214.57%
Nov 5, 2025
Maintains: Buy
Price Target: $90 → $100
Current: $56.21
Upside: +77.90%
Oct 27, 2025
Upgrades: Buy
Price Target: $14
Current: $3.43
Upside: +308.76%
Oct 27, 2025
Initiates: Buy
Price Target: $70
Current: $57.95
Upside: +20.79%
Oct 27, 2025
Initiates: Buy
Price Target: $60
Current: $35.07
Upside: +71.09%
Oct 10, 2025
Maintains: Buy
Price Target: $101 → $150
Current: $124.13
Upside: +20.84%
Oct 8, 2025
Maintains: Buy
Price Target: $112 → $128
Current: $7.30
Upside: +1,653.42%
Sep 30, 2025
Maintains: Buy
Price Target: $80 → $20
Current: $18.19
Upside: +9.95%
Sep 18, 2025
Reiterates: Buy
Price Target: $1,070
Current: $826.18
Upside: +29.51%
Sep 9, 2025
Maintains: Buy
Price Target: $92 → $100
Current: $52.98
Upside: +88.75%
Aug 18, 2025
Initiates: Buy
Price Target: $75
Current: $28.43
Upside: +163.81%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $3.74
Upside: +301.61%
Aug 1, 2025
Maintains: Buy
Price Target: $165 → $175
Current: $131.12
Upside: +33.47%
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $5.90
Upside: +340.68%
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $15.38
Upside: +88.56%
May 2, 2025
Maintains: Buy
Price Target: $18 → $12
Current: $12.40
Upside: -3.23%
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $7.06
Upside: +112.46%
Mar 12, 2025
Reiterates: Buy
Price Target: $45
Current: $26.77
Upside: +68.10%
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $26.47
Upside: +70.02%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $24.76
Upside: -19.22%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.42
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $43.86
Upside: +48.20%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $30.19
Upside: +198.16%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.63
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $44.43
Upside: +10.29%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $17.50
Upside: +214.29%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.46
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $18.53
Upside: +29.52%